Observations

Medicine and the Media

Generic drugs: protest group was not quite what it seemed

BMJ 2010; 340 doi: 10.1136/bmj.c1514 (Published 17 March 2010)
Cite this as: BMJ 2010;340:c1514

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Margaret McCartney, general practitioner, Glasgow, and Financial Times columnist
  1. margaretmccartney{at}doctors.org.uk

    Last month the Times published a letter from doctors and patients’ groups warning against generic drugs and supporting branded prescribing. But who was really behind the protest? Margaret McCartney investigates

    Generics are good for us. That’s the mantra that is taught to doctors again and again: they are cheaper for the NHS but just as effective for the patient. So it was surprising to find a letter in the Times recently, signed by several doctors, decrying generics and pleading for doctors’ choice to prescribe branded drugs to be paramount. The letter, titled “Patient wellbeing at risk from substituted generic medicines,” was also signed by patients’ groups such as the Cure Parkinson’s Trust and the British Liver Trust and carried the names of the media doctor Patricia Macnair, Stephen Kownacki, chairman of the Primary Care Dermatology Society, and Jean Mossman, former chief executive of Cancer BACUP (www.timesonline.co.uk/tol/comment/letters/article7037957.ece).

    The letter was a response to the Department of Health’s current consultation on prescribing, which proposes an automatic generic substitution scheme (BMJ 2010;340:c135, 8 Jan, doi:10.1136/bmj.c135). The consultation aims to …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular